collection
https://read.qxmd.com/read/25663578/impact-of-time-to-antibiotics-on-outcomes-of-chemotherapy-induced-febrile-neutropenia
#1
JOURNAL ARTICLE
Byuk Sung Ko, Shin Ahn, Yoon-Seon Lee, Won Young Kim, Kyung Soo Lim, Jae-Lyun Lee
PURPOSE: The aim of this study was to determine the relationship between the time to antibiotic administration and patients' outcomes of febrile neutropenia (FN). We also investigated the relationship between the time to antibiotics and mortality rates in a subgroup of patients with bacteremia or severe sepsis or septic shock. METHODS: From the Neutropenic Fever Registry, we analyzed 1001 consecutive FN episodes diagnosed from November 1, 2011, to August 31, 2014...
September 2015: Supportive Care in Cancer
https://read.qxmd.com/read/25820366/society-of-gynecologic-oncology-recommendations-for-the-prevention-of-ovarian-cancer
#2
REVIEW
Joan L Walker, C Bethan Powell, Lee-May Chen, Jeanne Carter, Victoria L Bae Jump, Lynn P Parker, Mark E Borowsky, Randall K Gibb
Mortality from ovarian cancer may be dramatically reduced with the implementation of attainable prevention strategies. The new understanding of the cells of origin and the molecular etiology of ovarian cancer warrants a strong recommendation to the public and health care providers. This document discusses potential prevention strategies, which include 1) oral contraceptive use, 2) tubal sterilization, 3) risk-reducing salpingo-oophorectomy in women at high hereditary risk of breast and ovarian cancer, 4) genetic counseling and testing for women with ovarian cancer and other high-risk families, and 5) salpingectomy after childbearing is complete (at the time of elective pelvic surgeries, at the time of hysterectomy, and as an alternative to tubal ligation)...
July 1, 2015: Cancer
https://read.qxmd.com/read/25640813/daily-aspirin-may-reduce-mortality-from-prostate-cancer-with-risk-of-high-recurrence
#3
COMMENT
Mary Kay Barton
No abstract text is available yet for this article.
March 2015: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/19513024/temporal-association-of-changes-in-fasting-blood-glucose-and-body-mass-index-with-diagnosis-of-pancreatic-cancer
#4
JOURNAL ARTICLE
Rahul Pannala, Cynthia L Leibson, Kari G Rabe, Lawrence J Timmons, Jeanine Ransom, Mariza de Andrade, Gloria M Petersen, Suresh T Chari
OBJECTIVES: Although the association between diabetes mellitus (DM) and pancreatic cancer is well described, temporal patterns of changes in fasting blood glucose (FBG) and body mass index (BMI) before pancreatic cancer diagnosis are not known. METHODS: We reviewed the medical records of pancreatic cancer cases seen at the Mayo Clinic from 15 January 1981 through to 9 July 2004 and selected those residing within 120 miles of Rochester, MN and who were seen at the Mayo Clinic within 30 days of the date of cancer diagnosis (index date)...
September 2009: American Journal of Gastroenterology
https://read.qxmd.com/read/25296639/long-term-outcomes-following-microwave-ablation-for-liver-malignancies
#5
JOURNAL ARTICLE
U Leung, D Kuk, M I D'Angelica, T P Kingham, P J Allen, R P DeMatteo, W R Jarnagin, Y Fong
BACKGROUND: Microwave ablation has emerged as a promising treatment for liver malignancies, but there are scant long-term follow-up data. This study evaluated long-term outcomes, with a comparison of 915-MHz and 2.4-GHz ablation systems. METHODS: This was a retrospective review of patients with malignant liver tumours undergoing operative microwave ablation with or without liver resection between 2008 and 2013. Regional or systemic (neo)adjuvant therapy was given selectively...
January 2015: British Journal of Surgery
https://read.qxmd.com/read/25469808/intravenous-lidocaine-for-cancer-pain-without-electrocardiographic-monitoring-a-retrospective-review
#6
JOURNAL ARTICLE
Renata D'Alpino Peixoto, Pippa Hawley
BACKGROUND: Intravenous lidocaine infusion has been clearly demonstrated as effective for pain in randomized controlled trials, but the belief that cardiac monitoring is required for safe administration is a barrier to access in the palliative care setting. There are also multiple infusion protocols reported in the literature. We have been administering lidocaine infusions for severe cancer pain at the BC Cancer Agency (BCCA) since 2003, without electrocardiographic (ECG) monitoring. Our simple protocol is for 5 mg/kg to be infused over 1 hour, with the option for subsequent doses to be increased if necessary, up to a maximum of 10 mg/kg...
April 2015: Journal of Palliative Medicine
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.